Adolescents treated for obesity with GLP-1 drugs had lower risk of suicidal thoughts, study finds
A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to have suicidal thoughts or attempts than those treated with behavioral interventions.
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
Anti-obesity drugs tied to lower risk of suicidal thoughts or attempts among young people - study
Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged caution in interpreting the results.View on euronews
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct.
Study says Ozempic may reduce the risk of suicide in obese teens
The iconic movies everyone should watch at least once before they die, according to critics ‘Stunning’ hidden tomb found at Petra site featured in ‘Indiana Jones’ Steelers' Ben Roethlisberger Believes
Weight-loss drugs may be no obesity silver bullet
Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given ...
Ozempic boasts surprising mental health benefits for teens with obesity: new research
This research contradicts previous concerns about the potential of drugs like Ozempic to trigger suicidal ideation and ...
Pulse16m
GPs call for urgent obesity services review as demand for new drugs rises
A group of health professionals have called for a review of obesity management services in light of increased public demand ...
Could Weight-Loss Drugs Help Get People Back to Work? The U.K. Wants to Find Out.
The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...
Amgen’s stock falls as analyst warns that hype around obesity drug is baked in
Truist analyst Srikripa Devarakonda backs away from bullish call as competition mutes potential for biotech’s drug pipeline.
MedPage Today1d
Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancer
Opens in a new tab or window Bayer said the FDA is reviewing its investigational drug elinzanetant for moderate-to-severe ...
New drug approach could underpin future weight loss therapies, study indicates
Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related ...
Rochdale Online6h
Obesity drug trial coming to Greater Manchester
A major trial is coming to Greater Manchester to see how a new drug can tackle obesity. The ‘five-year real-world evidence study’ will be run by Health Innovation Manchester and pharmaceutical giant ...
The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?
The United States has passed peak obesity, according to new data, suggesting that the sweeping uptake of weight-loss drugs ...
Lilly to Invest $364 Million in UK Biotech, Obesity Research
Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of ...
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a ...